Opus Genetics, Inc. generated $14.2M in revenue in fiscal year 2025. This represents an increase of 29.1% from the prior fiscal year. Over the trailing 12 months, Q4 FY2025 through Q3 FY2026, the same line adds up to $7.9M in revenue. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Opus Genetics, Inc. has filed alongside them.
Ticker history: OCUP became IRD (Opus Genetics, Inc.) on . Earlier news and filings retain their original names and dates. View OCUP history.
Annual figures, oldest first. Point at a bar to read its period.
IRD Revenue by Fiscal Year
Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.
IRD Revenue by Quarter
Figures are in USD. Each change compares the quarter with the same quarter a year earlier.
What revenue means
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.
More Opus Genetics, Inc. financials
Frequently Asked Questions
Opus Genetics, Inc. generated $14.2M in revenue in fiscal year 2025.
Opus Genetics, Inc. (IRD) revenue rose by 29.1% year over year, from $11.0M to $14.2M in fiscal year 2025.
Opus Genetics, Inc. (IRD) reported $7.9M in revenue over the trailing 12 months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.
Across the 15 fiscal years this page covers, Opus Genetics, Inc. (IRD) revenue went from $0 in fiscal year 2011 to $14.2M in fiscal year 2025.
Opus Genetics, Inc. (IRD) reported $1.1M in revenue in Q3 2026. This represents a decrease of 63.1% from the same quarter a year earlier.
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Opus Genetics, Inc. (IRD) reported on that line in every period on record.